Viewing Study NCT06186804


Ignite Creation Date: 2025-12-24 @ 8:03 PM
Ignite Modification Date: 2025-12-25 @ 5:35 PM
Study NCT ID: NCT06186804
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2024-08-12
First Post: 2023-11-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase II Study Evaluating the Efficacy and Safety of ABSK021 (Pimicotinib)) in the Treatment of cGvHD Chronic Graft Versus Host Disease (cGvHD)
Sponsor: Abbisko Therapeutics Co, Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module